Additional file 1: of Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

Table S1. Institutional Review Board or Ethics Committee of Each Participating Site. Description of data: Provides details of institutional review board/ethics committees for each participating site. (PDF 118 kb)